hi-stem.de - HI-STEM - Institute for Stem Cell Technology

Example domain paragraphs

Solid Tumors and Metastasis Solid Tumors, Metastasis & Therapy Resistance Read more Hematopoietic Stem Cells and Leukemia Hematopoietic Stem Cells and Leukemia Read more Stem Cells and Tumor Microenvironment Stem Cells and Tumor Microenvironment Read more The HI-STEM Team The HI-STEM Team HI-STEM features an interdisciplinary research team. HI-STEM Group Leaders HI-STEM Group Leaders Movie Slide Watch the HI-STEM Movie! HI-STEM: The Heidelberg Institute for Stem Cell Technology and Experimental Medicine HI-

Researchers at HI-STEM are working in close collaboration with clinical colleagues of the University Hospitals in Heidelberg and Mannheim as well as with the National Center for Tumor Diseases (NCT) in Heidelberg and members of the German Cancer Consortium (DKTK) as well as international collaborators. In addition, HI-STEM collaborates with various biotechnology and pharmaceutical companies to investigate and develop novel strategies to push forward the development of new drugs and effective treatments for

July 26, 2022 Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (Cell Stem Cell, 2022) May 05, 2022 Antigen presentation safeguards the integrity of the hematopoietic stem cell pool (Cell Stem Cell, 2022) May 03, 2022 CRISPR-Cas9 mediated generation of a conditional poly(A) binding protein nuclear 1 (Pabpn1) mouse model reveals an essential role for hematopoietic stem cells (Scientific Reports, 2022) April 28, 2022 Perivascular tenascin

Links to hi-stem.de (4)